Abbott reports Q1 worldwide Medical Devices sales up 8.5% on reported basis

Worldwide Medical Devices sales increased 8.5% on a reported basis and 12.4% on an organic basis in the first quarter, including double-digit organic sales growth in both the U.S. and internationally. Sales growth was led by double-digit organic growth in Diabetes Care, Structural Heart, Heart Failure and Neuromodulation. Several recently launched products and new indications contributed to the strong performance, including Amplatzer Amulet, Navitor, TriClip, Aveir and CardioMEMS. In Electrophysiology, internationally, sales grew double-digits on a reported basis and high-teens on an organic basis in Europe, which was partially offset by soft market conditions in China during the first several weeks of the first quarter. In Diabetes Care, FreeStyle Libre sales were $1.2B, which included U.S. growth of approximately 50%.